Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Book value per share

Alert me on Book value per share

Bristol Myers Squibb Company's book value per share at the end of fiscal 2025 was 9.1×, up 12.5% from 8.1× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 10.9×. Over the past ten years it has ranged from 7.2× (fiscal 2017) to 30.3× (fiscal 2019); the current reading is higher than 45% of that period. Bristol Myers Squibb Company ranks 12th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 9.1× 12.53%
FY2024 8.1× (43.27%)
FY2023 14.3× (2.45%)
FY2022 14.6× (9.88%)
FY2021 16.2× (3.37%)
FY2020 16.8× (44.67%)
FY2019 30.3× 250.50%
FY2018 8.7× 20.12%
FY2017 7.2× (26.38%)
FY2016 9.8× 13.06%

Quarterly newest first

Period Book value per share Change
Jun 2026 10.9× 10.81%
Mar 2026 9.9× 8.41%
Dec 2025 9.1× (0.41%)
Sep 2025 9.1× 6.30%
42 more quarters

Against its own ten years

Low 7.2× High 30.3×
Ten-year median 9.8×
Current reading's percentile 45

Book value per share against peers

Company Book value per share
SNY Sanofi compare 33.8×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
PFE Pfizer Inc. compare 15.0×
GSK GSK PLC Sponsored ADR compare 11.5×
BMY Bristol Myers Squibb Company 10.9×
GILD Gilead Sciences, Inc. compare 9.4×
NVO Novo Nordisk A/S compare 7.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BMY